MACROLIDES AND TOREMIFENE
Based on theoretical considerations, the manufacturers advise care when toremifene is
given with inhibitors of CYP3A such as the macrolides (they specifically name
erythromycin, see macrolides, for more detail).
It would seem prudent to monitor for toremifene adverse effects (e.g. hot flushes, uterine bleeding, fatigue, nausea, dizziness) on concurrent use with the macro- lides.
given with inhibitors of CYP3A such as the macrolides (they specifically name
erythromycin, see macrolides, for more detail).
It would seem prudent to monitor for toremifene adverse effects (e.g. hot flushes, uterine bleeding, fatigue, nausea, dizziness) on concurrent use with the macro- lides.